These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6432726)

  • 1. Rectal administration of sodium valproate in children.
    Scanabissi E; Dal Pozzo D; Franzoni E; Galloni C; Mengoli G; Calivà R
    Ital J Neurol Sci; 1984 Jun; 5(2):189-93. PubMed ID: 6432726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effectiveness of several formulations of sodium valproate: tablets, enteric-coated capsules, solutions and rectal capsules.
    Battino D; Biraghi M; Cusi C; Nespolo A; Avanzini G
    Ital J Neurol Sci; 1982 Oct; 3(3):197-200. PubMed ID: 6819250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of valproate during maintenance therapy in epileptic children.
    Lundberg B; Nergårdh A; Boréus LO
    J Neurol; 1982; 228(2):133-41. PubMed ID: 6185649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of childhood epilepsy with rectal valproate: case reports and pharmacokinetic study.
    Kanazawa O; Sengoku A; Kawai I
    Brain Dev; 1987; 9(6):615-20. PubMed ID: 3128135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of sodium valproate suppositories during repeated administration at steady state in epileptic children.
    Issakainen J; Bourgeois BF
    Eur J Pediatr; 1987 Jul; 146(4):404-7. PubMed ID: 3115782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy.
    Dedeurwaerdere S; van Raay L; Morris MJ; Reed RC; Hogan RE; O'Brien TJ
    Seizure; 2011 Jan; 20(1):72-9. PubMed ID: 21093310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of age, body weight and dose on sodium valproate plasma concentrations in children with epilepsy].
    Jiang Z; Zhang J; Liao HM; Tang JW; Peng QL
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):325-8. PubMed ID: 18554460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate: pharmacokinetics and effectivensss in treating intractable seizures.
    Redenbaugh JE; Sato S; Penry JK; Dreifuss FE; Kupferberg HJ
    Neurology; 1980 Jan; 30(1):1-6. PubMed ID: 6985719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid free fraction in epileptic children under chronic monotherapy.
    Riva R; Albani F; Franzoni E; Perucca E; Santucci M; Baruzzi A
    Ther Drug Monit; 1983 Jun; 5(2):197-200. PubMed ID: 6410546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of total and free valproic acid during monotherapy in infants.
    Herngren L; Lundberg B; Nergårdh A
    J Neurol; 1991 Sep; 238(6):315-9. PubMed ID: 1940980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of vigabatrin and valproate in children with refractory epilepsy.
    Armijo JA; Arteaga R; Valdizán EM; Herranz JL
    Clin Neuropharmacol; 1992 Dec; 15(6):459-69. PubMed ID: 1477847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronopharmacokinetic study of valproic acid in man: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ogawa N
    J Clin Pharmacol; 1989 Nov; 29(11):1048-52. PubMed ID: 2513338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy.
    Löscher W; Nau H; Siemes H
    Epilepsia; 1988; 29(3):311-6. PubMed ID: 3131137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of sodium valproate in childhood epilepsy.
    McQueen JK; Blackwood DH; Minns RA; Brown JK
    Scott Med J; 1982 Oct; 27(4):312-7. PubMed ID: 6815799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performances.
    Brouwer OF; Pieters MS; Edelbroek PM; Bakker AM; van Geel AA; Stijnen T; Jennekens-Schinkel A; Lanser JB; Peters AC
    Epilepsy Res; 1992 Dec; 13(3):245-53. PubMed ID: 1493787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinicopharmacological study of serum sodium valproate free level in children with epilepsy].
    Furuya M; Hashimoto K; Kamayachi S; Fujino O
    Nihon Ika Daigaku Zasshi; 1990 Dec; 57(6):513-23. PubMed ID: 2286644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.
    Mihaly GW; Vajda FJ; Miles JL; Louis WJ
    Eur J Clin Pharmacol; 1979 Aug; 16(1):23-9. PubMed ID: 387418
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of rectally administered valproic acid syrup.
    Cloyd JC; Kriel RL
    Neurology; 1981 Oct; 31(10):1348-52. PubMed ID: 6810203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.